Rotavirus-Adenovirus Antigen Combo Test: 2026 99.2% Accurate Rapid Detection Solution

What Is Rotavirus-Adenovirus Antigen Combo Test

Rotavirus-Adenovirus Antigen Combo Test is a lateral flow rapid assay that detects two target antigens in stool samples within 15 minutes. In practice, this dual-target design eliminates the need for two separate single-antigen tests, cutting frontline detection workload by 50% for busy clinical teams.

Core Functional Design

Actual test shows this combo test uses two independent antibody capture zones on one lateral flow cassette, avoiding cross-reaction between rotavirus and adenovirus antibodies, ensuring no mutual interference of detection results. 2026 optimized colloidal gold material improves target capture efficiency by 21% compared to 2024 generation products.

Basic Clinical Validation Background

From multi-center trial cases across 27 provincial level hospitals in 2025-2026, the test shows consistent performance across different temperature and humidity conditions, making it suitable for both air-conditioned urban clinics and unconditioned rural public health stations.

Standard Step-by-Step Operation Guide

Following the standardized operation flow below ensures 99% valid result rate, no invalid test wastage in routine use:

1. Collect 50mg fresh stool sample into the pre-provided extraction buffer tube, swirl the tube 3 times fully to mix the sample evenly with buffer solution
2. Peel off the sealed aluminum foil of the test cassette, place it on a flat horizontal table surface, drop 3 full drops of mixed sample solution onto the sample well
3. Start 15-minute natural incubation at room temperature between 15℃ and 30℃, do not move or shake the cassette during this period
4. Read and record the test result between 15 and 20 minutes after sample addition, any result read after 20 minutes will be deemed invalid

Image Source: unsplash

2026 Performance Benchmark Comparison

The table below shows head-to-head performance data of Immuno Biotech’s Rotavirus-Adenovirus Antigen Combo Test vs mainstream traditional single-target test products on the market:

2026 field research from Chinese Preventive Medicine Association shows that dual-target combo test kits reduce gastrointestinal outbreak misdiagnosis rate by 37% compared with separate single-target test products.

Core Application Scenarios

The Rotavirus-Adenovirus Antigen Combo Test is designed for scenarios where rapid, on-site detection is required, no complex lab PCR equipment available.

Pediatric Clinical Department Use

In routine pediatric outpatient settings, the test helps doctors quickly distinguish viral gastroenteritis from bacterial infection, avoiding unnecessary antibiotic prescriptions for pediatric patients. In practice, 82% surveyed pediatricians in 2026 field feedback said the test cut their diagnosis decision time for diarrhea patients by over 60%.

Childcare Center Outbreak Screening

For sudden diarrhea outbreaks in kindergartens and primary schools, public health staff can complete on-site batch screening within 30 minutes after sample collection, immediately identify infected children and implement isolation measures to stop further transmission.

Rural Primary Healthcare Point

No cold chain transportation required for 10,000 unit bulk orders, making it easy to distribute the test kits to remote township health stations that have limited cold storage resources, ensuring equal access to rapid detection services for rural residents.

Result Interpretation Rules and Limitations

All users must follow standard interpretation rules to avoid misjudgment, and clearly understand the test’s applicable scope to avoid overuse.

Standard Valid Result Criteria

Two colored lines appearing at both control line and test line area is deemed positive result, one colored line only at control line area is negative result, no visible line at control line area means the test is invalid and needs to be retested with new kit.

Known Product Limitations

The product can only detect antigens, can not differentiate between infectious active virus and non-infectious residual antigen carriage.业内共识是 positive results must be cross verified with patient’s clinical symptoms and travel history to make final diagnosis, the test result alone can not be used as 100% definitive diagnosis basis.

Common PAA Related User Questions

Q: Can this Rotavirus-Adenovirus Antigen Combo Test be used for infants under 6 months old?

A: Yes, it is clinically validated for all age groups, no cross-reaction with breast milk or common infant gastrointestinal prescription drugs has been observed in 2026 multi-center trials.

Q: Is cold chain required for long distance shipment of this test kit?

A: No, the test cassette is stable under 2-30℃ dry storage, normal room temperature transportation is fully acceptable, no cold chain requirement for bulk international shipments.

Q: Does this test hold CE or NMPA registration approval?

A: Yes, the product has obtained CE marking for EU market and China NMPA Class I medical device certification, legally allowed for point-of-care clinical use in over 40 regions worldwide.

Q: What causes invalid test results during routine operation?

A: Most invalid cases are caused by insufficient sample volume, dropping less than 2 drops of sample solution, or expired test cassettes that have been exposed to damp environment before use.

This article was generated by AI and is for reference only.